Andere Sprachen Lophos Holdings Inc.

Aktien

A3ETGW

CA5439371066

MESC

Markt geschlossen - Canadian Securities Exchange Andere Börsenplätze 19:08:53 09.05.2024			% 5 Tage	% 1. Jan.
0,05 ^CAD	-9,09 %		0,00 %	+25,00 %

28.03.	Lophos Holdings Inc. kündigt Änderungen im Vorstand an	CI
14.02.	Lophos Holdings Inc. schließt die Entwicklung eines neuen Forschungsprotokolls für Lophophora Williamsii (Peyote) ab	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Lophos Pharmaceuticals Corp. Enters Into Letter of Intent to Acquire the Assets of Magicactus.com	06.05.
Lophos Pharmaceuticals Corp. Commences Peyote Research Protocol	02.05.
Lophos Pharmaceuticals Corp. Expands Peyote Cultivation with the Successful Planting of 3,000 Seeds	25.04.
Lophos Pharmaceuticals’ Licensed Site Celebrates Successful Building Occupancy	17.04.
ThreeD Capital Inc. and Lophos Holdings Inc. Announce Strategic Partnership	15.04.
ThreeD Capital Inc. Announces Securities Purchase Agreement with Lophos Holdings Inc.	15.04.
ThreeD Capital Inc. announced that it expects to receive CAD 0.1275 million in funding from Lophos Holdings Inc.	15.04.
ThreeD Capital Inc. entered into a securities purchase agreement to acquire 2.5% stake in Lophos Holdings Inc. for CAD 0.05 million.	15.04.
Lophos Holdings Inc. Celebrates Successful Conclusion of Inaugural Annual General Meeting, Confirms Board Members and Stock Options Plan	28.03.
Lophos Holdings Inc. Announces Board Changes	28.03.
Lophos Pharmaceuticals Partners With Carmichael Engineering Ltd. for HVAC Project, Anticipates Expedited Building Occupancy	05.03.
Lophos Confirms Appearance at Benzinga Capital Conference in Hollywood, Florida and Finalizes Annual General Meeting	28.02.
Lophos Holdings Inc. Finalizes the Development of a New Research Protocol for Lophophora Williamsii	14.02.
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Research Protocol for Lophophora Williamsii (Peyote)	14.02.
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Synthetic Mescaline Protocol	08.02.
Lophos Pharmaceuticals Corp. Finalizes the Development of A New Synthetic Mescaline Protocol	08.02.
Lophos Pharmaceuticals Corp. Finalizes Product Release Specifications for Fresh and Dried Peyote (Lophophora williamsii)	31.01.
Health Canada Endorses Lophophora Williamsii, Elevating Lophos Holdings Inc. as a Leader in Natural Health Innovation	23.01.
Lophos Pharmaceuticals Corp. Receives Health Canada Approval for Expanded Controlled Substance Operations Following HVAC Revisions	22.11.
Lophos Holdings Inc.'s Subsidiary Lophos Pharmaceuticals Corp. Receives Health Canada Approval for Expanded Controlled Substance Operations Following HVAC Revisions	22.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Lophos Holdings Inc.

Aktien

A3ETGW

CA5439371066

MESC

Andere Sprachen

Filter